MAKE WAY FOR THE FIRST ACTIVE HEMOSTATIC POWDER

MAKE WAY FOR THE FIRST ACTIVE HEMOSTATIC POWDER

SURGICAL BLEEDING IS A BURDEN FOR HOSPITAL BUDGETS

– Excess cost of 1,806 € can be linked to bleeding during surgery(1)

– Length of hospital stay increases by an average 3.38 days in case of bleeding(1)

BLEEDING CAUSES EXCESS COSTS IN ALL TYPES OF SURGERY(1)

1. Ye X, et al. Incidence and costs of bleeding-related complications in French hospitals following surgery for various diagnoses. BMC Health Serv Res 2013;13:186.

Legal Information: HEMOBLAST™ Bellows - Implantable Medical device Class III for surgery reserved for use by qualified healthcare professionals, reimbursement depends on each country.
Read the instructions for use on the packaging carefully before use. CE0086: BSI - Manufacturer: Biom’up SA France.